维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

18篇 您的检索式：作者名="Muller EB"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	ABCB1(MDR1)-type P-glycoproteins at the blood-brainbarrier modulate the activity of the Hypothalamic-Pituitary-Adrenocortical system:implications for af-fective disorder显示文摘	Muller MB Keck ME Binder EB	2003	Neuropsychopharmacology2003，28，11：	1
	2	Ziprasidone-related tardiye dyskinesia显示文摘	Keck ME Muller MB Binder EB	2004	Am J Psychiatry2004，161，1：	1
	3	Impacts of metal oxide nanoparticles on marine phytoplankton显示文摘	Miller R J Lenihan HS Muller EB	2010	Environmental Science & Technology2010，44，19：	1
	4	TH1 and TH2 T cell subsets are differentially activated by macrophages and B ceils in murine leishmaniasis 显示文摘	Rossi-Bergmann B Muller I Godinho EB	1993	Infect Immun1993，61，5：	1
	5	Development of con- trolled release formulation based on SLN and NLC for topical clot- rimazole delivery显示文摘	SOUTO EB WISSING SA MULLER RH	2004	lnt J Pharm2004，278，1：	1
	6	Zirasidone-Related Tardive Dyskinesia显示文摘	Keck ME Muller MB Binder EB	2004	Am J Psychiatry2004，161，1：	1
	7	The use of SLN and NLC as topical particulate carriers for imidazole antifungal agents显示文摘	SOUTO EB MULLER RH	2006	Pharmazie2006，61，5：	1
	8	Physicochemical investigations on the structure of drug-free and drug- loaded solid lipid nanoparticles (SLN) by means of DSC and IH-NMR显示文摘	Zimmermann E Souto EB Muller RH	2005	Pharmazie2005，60，7：	1
	9	ABCB1 (MDR1)-type P-glycoproteins at the blood-brain barri- er modulate the activity of the hypothalamic-pituitary- adrenocortieal system: implications for affective disor- der 显示文摘	Muller MB Keck ME Binder EB	2003	Neuropsychopharmacology2003，28，11：	1
	10	Ziprasidone-related tardive dyskinesia显示文摘	Keck ME Muller MB Binder EB	2004	Am J Psychiatry2004，161，1：	1
	11	Lipid nanoparticles: effect on bioavailability and pharmacokinetic changes 显示文摘	Souto EB Muller RH	2010	Handb Exp Pharmacol2010，197，：	1
	12	Solid lipid nanoparticles and nanostructured lipid carriers for topical delivery of ketoconazole 显示文摘	SOUTO EB MULLER RH	2005	J Microencapsul2005，22，5：	1
	13	Polymorphic behaviour of Compritol888 ATO as bulk lipid and as SLN and NLC显示文摘	Souto EB Mehnert W Muller RH		0，，：	1
	14	The use of SLN and NLC as topical particulate carriers for imidazole anti-fungal agents 显示文摘	SOUTO EB MULLER RH	2006	Pharmazie2006，61，5：	1
	15	SLN and NLC for topical delivery of keto-conazole显示文摘	Souto EB Muller RH		0，，：	1
	16	Ziprasidone-related tardive dyskinesia显示文摘	Keck ME Muller MB Binder EB	2004	Am J Psychiatry2004，161，1：	1
	17	Investigation of the factors influencing the incorporation of clotrimazole in SLN and NLC prepared by hot high-pressure homogenization 显示文摘	SOUTO EB MULLER RH	2006	J Microencapsul2006，23，4：	1
	18	Polymorphlc behaviour of Compritol888 ATO as bulk lipid and as SLN and NLC 显示文摘	SOUTO EB MEHNERT W MULLER RH	2006	J Microencapsul2006，23，4：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费